Ambulance heat may not spoil life-saving bleeding treatments
NCT ID NCT07646964
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether two blood-clotting products — human fibrinogen and freeze-dried plasma — remain stable when stored in an ambulance under everyday conditions, including summer heat. Researchers in Graz, Austria, will compare samples stored in the ambulance with ones kept under ideal conditions over four months. The goal is to see if current storage practices in emergency vehicles are good enough to keep these products effective for treating severe bleeding.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- human fibrinogen (Fibryga) and lyophilized human plasma (Octaplas LG AB)
- What this could lead to
- If these products remain stable, it could confirm that current ambulance storage practices are safe for emergency bleeding treatments.
- What could go wrong
- This is a very small observational study (only 2 samples) in one city, so results may not apply to other settings or climates.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EXANGUINATION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.